Levo-tetrahydropalmatine inhibits the acquisition of ketamine-induced conditioned place preference by regulating the expression of ERK and CREB phosphorylation in rats

Du, Yan and Du, Li and Cao, Jie and Holscher, Christian and Feng, Yongming and Su, Hongliang and Wang, Yujin and Yun, Ke-Ming (2017) Levo-tetrahydropalmatine inhibits the acquisition of ketamine-induced conditioned place preference by regulating the expression of ERK and CREB phosphorylation in rats. Behavioural Brain Research, 317. pp. 367-373. ISSN 0166-4328

[img]
Preview
PDF (Ketamine paper)
Ketamine_paper.pdf - Accepted Version
Available under License Creative Commons Attribution-NonCommercial-NoDerivs.

Download (289kB)

Abstract

Abstract Levo-tetrahydropalmatine (l-THP) is an alkaloid purified from the Chinese herbs Corydalis and Stephania and has been used in many traditional Chinese herbal preparations for its sedative, analgesic and hypnotic properties. Previous studies demonstrated that l-THP has antagonistic activity on dopamine receptors; thus, it may have potential therapeutic effects on drug abuse. However, whether l-THP affects ketamine-induced conditioned place preference (CPP) remains unclear. Therefore, the present study was designed to evaluate the effects of l-THP on the rewarding behavior of ketamine through CPP. Results revealed that ketamine (5, 10 and 15 mg/kg) induced CPP in rats. Furthermore, Ketamine (10 mg/kg) promoted the phosphorylation of extracellular-regulated kinase (ERK) and cAMP responsive element binding protein (CREB) in the hippocampus (Hip) and caudate putamen (CPu), but not in the prefrontal cortex (PFc). l-THP (20 mg/kg) co-administered with ketamine during conditioning inhibited the acquisition of ketamine-induced CPP in rats. Furthermore, l-THP (20 mg/kg) prevented the enhanced phosphorylation of ERK and CREB in CPu and Hip. These results suggest that l-THP has potential therapeutic effects on ketamine-induced CPP. The underlying molecular mechanism may be related to its inhibitory effect on ERK and CREB phosphorylation in Hip and CPu. The present data supports the potential use of l-THP for the treatment of ketamine addiction.

Item Type: Journal Article
Journal or Publication Title: Behavioural Brain Research
Additional Information: This is the author’s version of a work that was accepted for publication in Behavioural Brain Research. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Behavioural Brain Research, 317, 2017 DOI: 10.1016/j.bbr.2016.10.001
Uncontrolled Keywords: /dk/atira/pure/subjectarea/asjc/2800/2802
Subjects:
Departments: Faculty of Health and Medicine > Biomedical & Life Sciences
ID Code: 82911
Deposited By: ep_importer_pure
Deposited On: 11 Dec 2017 15:20
Refereed?: Yes
Published?: Published
Last Modified: 19 Feb 2020 03:29
URI: https://eprints.lancs.ac.uk/id/eprint/82911

Actions (login required)

View Item View Item